AKESF Stock Price Chart
AKESF Price
Akeso, Inc.
$0
0%
$0
At close: Sep 02, 16:00:00 GMT-4
$0
0%
$0
Post-market: Sep 02, 19:42:15 GMT-4
Back
Akeso, Inc. (AKESF) Price
Key Stats
Prev.Close
--
Open
--
Day's Range
-
52 week range
-
Volume
--
Avg.Volume
1.5K
Dividend yield
--
EPS (TTM)
-0.16
Market Cap
--
What is AKESO INC.?
Akeso, Inc. Is an investment company, which engages in the research and development, production, and sale of biopharmaceuticals products. The company employs 3,761 full-time employees The company went IPO on 2020-04-24. The Company’s programs covering the therapeutic areas of oncology, autoimmune and metabolic diseases. The firm's products mainly include cadonilimab (PD-1/CTLA-4), ivonescimab (PD-1/VEGF), Ligufalimab (AK117, CD47), Pulocimab (AK109, VEGFR-2), ANNIKO (penpulimab, PD-1), and tagitanlimab (PD-L1) used in oncology fields as well as ebronucimab (PCSK9), ebdarokimab (IL-12/IL-23), and Gumokimab (AK111, IL-17) used in metabolic and autoimmune therapeutic fields.
